Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Interest & Investment Income: 2024-2025

  • Abivax's Interest & Investment Income rose 1.77% to $4.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $16.0 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 81.58% up from last year.
  • As of Q2 2025, Abivax's Interest & Investment Income stood at $4.0 million, which was up 142.47% from $1.6 million recorded in Q1 2025.
  • Abivax's Interest & Investment Income's 5-year high stood at $6.6 million during Q1 2024, with a 5-year trough of $1.6 million in Q1 2025.
  • Its 2-year average for Interest & Investment Income is $4.0 million, with a median of $3.9 million in 2024.
  • Examining YoY changes over the last 5 years, Abivax's Interest & Investment Income showed a top increase of 1.77% in 2025 and a maximum decrease of 75.08% in 2025.
  • Over the past 2 years, Abivax's Interest & Investment Income (Quarterly) stood at $3.9 million in 2024, then grew by 1.77% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q2 2025, $1.6 million for Q1 2025, and $3.9 million during Q2 2024.